BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $18,623,000 | +16.4% | 367,537 | -8.1% | 1.13% | +9.2% |
Q1 2017 | $15,996,000 | +1855.5% | 400,000 | +1352.5% | 1.04% | +1496.9% |
Q3 2016 | $818,000 | +42.5% | 27,539 | -2.9% | 0.06% | +18.2% |
Q2 2016 | $574,000 | +17.6% | 28,353 | +4.8% | 0.06% | +10.0% |
Q1 2016 | $488,000 | -93.3% | 27,055 | -90.2% | 0.05% | -90.8% |
Q4 2015 | $7,288,000 | -7.1% | 276,687 | -24.7% | 0.54% | -8.2% |
Q3 2015 | $7,842,000 | -18.9% | 367,485 | -2.8% | 0.59% | -25.1% |
Q2 2015 | $9,671,000 | – | 378,235 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |